📊 AIBT Key Takeaways
Is Aibotics, Inc.. (AIBT) a Good Investment?
Aibotics is a non-viable business with catastrophic financial deterioration and zero operational momentum. The company generated only $2.2K in revenue while burning $1.6M in net losses and $371.6K in operating cash outflows, indicating no viable revenue model or path to profitability. With negative stockholders' equity of -$3.9M, liabilities exceeding assets by 4.8x, and a current ratio of 0.05x, the company faces imminent insolvency and is operationally insolvent.
AIBOTICS, INC. shows extremely weak fundamentals: revenue is negligible at $2.18K while operating and net losses exceed $1.3M and $1.6M, indicating the business is not commercially viable at its current scale. Financial health is highly stressed, with negative equity, a 0.05x current ratio, and negative operating cash flow, which together point to substantial solvency and funding risk. Growth quality appears poor because losses and cash burn are far out of proportion to the company’s revenue base.
Why Buy Aibotics, Inc.. Stock? AIBT Key Strengths
- Positive gross margin at 100% on minimal revenue indicates products sold generate full margins
- Positive gross profit and reported 100% gross margin, indicating current revenue carries no reported direct cost burden
- No capital expenditure requirement in the latest period, suggesting limited near-term reinvestment needs for fixed assets
- Cash balance of $230.47K provides some near-term operating flexibility despite severe financial strain
AIBT Stock Risks: Aibotics, Inc.. Investment Risks
- Negative stockholders equity of -$3.9M indicates technical insolvency
- Revenue of only $2.2K with operating losses of $1.4M demonstrates no viable business model
- Current ratio of 0.05x with liabilities 4.8x assets indicates acute liquidity crisis and default risk
- Negative operating cash flow of -$371.6K with zero capex indicates cash burn with no reinvestment
- ROA of -158.1% and operating margin of -62,776% show severe operational dysfunction
- No insider activity in 90 days suggests loss of management confidence
- Cash position of $230.5K insufficient to cover monthly burn rate
- Revenue base is de minimis relative to the cost structure, making the business model currently unsustainable
- Negative stockholders’ equity of $3.89M and total liabilities far above assets indicate serious balance-sheet weakness
- Very poor liquidity and negative operating cash flow increase the likelihood of additional external financing or restructuring pressure
Key Metrics to Watch
- Monthly cash burn rate and runway remaining before depletion
- Revenue growth trajectory and ability to scale beyond negligible levels
- Debt restructuring or recapitalization announcements
- Stockholders equity recovery to positive territory
- Revenue scaling relative to operating expense growth
- Operating cash flow and current ratio
Aibotics, Inc.. (AIBT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AIBT Profit Margin, ROE & Profitability Analysis
AIBT vs Materials Sector: How Aibotics, Inc.. Compares
How Aibotics, Inc.. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Aibotics, Inc.. Stock Overvalued? AIBT Valuation Analysis 2026
Based on fundamental analysis, Aibotics, Inc.. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Aibotics, Inc.. Balance Sheet: AIBT Debt, Cash & Liquidity
AIBT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Aibotics, Inc..'s revenue has remained relatively flat over the 5-year period, with a 0% decline.
AIBT Revenue Growth, EPS Growth & YoY Performance
AIBT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | N/A | -$425.9K | N/A |
| Q2 2025 | N/A | -$425.9K | N/A |
| Q1 2025 | N/A | -$425.9K | N/A |
| Q3 2019 | $3.3M | N/A | N/A |
| Q2 2019 | $3.4M | N/A | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Aibotics, Inc.. Dividends, Buybacks & Capital Allocation
AIBT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Aibotics, Inc.. (CIK: 0001763329)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AIBT
What is the AI rating for AIBT?
Aibotics, Inc.. (AIBT) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 95% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AIBT's key strengths?
Claude: Positive gross margin at 100% on minimal revenue indicates products sold generate full margins. ChatGPT: Positive gross profit and reported 100% gross margin, indicating current revenue carries no reported direct cost burden. No capital expenditure requirement in the latest period, suggesting limited near-term reinvestment needs for fixed assets.
What are the risks of investing in AIBT?
Claude: Negative stockholders equity of -$3.9M indicates technical insolvency. Revenue of only $2.2K with operating losses of $1.4M demonstrates no viable business model. ChatGPT: Revenue base is de minimis relative to the cost structure, making the business model currently unsustainable. Negative stockholders’ equity of $3.89M and total liabilities far above assets indicate serious balance-sheet weakness.
What is AIBT's revenue and growth?
Aibotics, Inc.. reported revenue of $2.2K.
Does AIBT pay dividends?
Aibotics, Inc.. does not currently pay dividends.
Where can I find AIBT SEC filings?
Official SEC filings for Aibotics, Inc.. (CIK: 0001763329) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AIBT's EPS?
Aibotics, Inc.. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AIBT a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Aibotics, Inc.. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AIBT stock overvalued or undervalued?
Valuation metrics for AIBT: ROE of N/A (sector avg: 14%), net margin of -73,635.7% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AIBT stock in 2026?
Our dual AI analysis gives Aibotics, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AIBT's free cash flow?
Aibotics, Inc..'s operating cash flow is $-371.6K, with capital expenditures of $0.0. FCF margin is -17,024.1%.
How does AIBT compare to other Materials stocks?
Vs Materials sector averages: Net margin -73,635.7% (avg: 10%), ROE N/A (avg: 14%), current ratio 0.05 (avg: 1.6).